Free Trial

Aligos Therapeutics (ALGS) SEC Filings & 10K Form

$0.58
-0.02 (-3.33%)
(As of 05/24/2024 ET)

Recent Aligos Therapeutics SEC Filings

DateFilerForm TypeView
05/15/2024
4:01 PM
Aligos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
4:27 PM
Aligos Therapeutics (Filer)
Form PRE 14A
03/12/2024
3:51 PM
Aligos Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2024
3:15 PM
Aligos Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2024
4:44 PM
Aligos Therapeutics (Issuer)
McClure Matthew W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:41 PM
Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:42 PM
Aligos Therapeutics (Issuer)
Symons Julian A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:42 PM
Aligos Therapeutics (Issuer)
Calhoun Lesley Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
4:28 PM
Aligos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
4:29 PM
Aligos Therapeutics (Issuer)
Martell Bridget A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
4:29 PM
Aligos Therapeutics (Issuer)
Nuechterlein Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
4:30 PM
Aligos Therapeutics (Issuer)
Nielsen Jack (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
4:31 PM
Aligos Therapeutics (Issuer)
Symons Julian A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
4:32 PM
Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
4:32 PM
Aligos Therapeutics (Issuer)
Calhoun Lesley Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
4:33 PM
Aligos Therapeutics (Issuer)
McClure Matthew W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
4:34 PM
Aligos Therapeutics (Issuer)
Scopa James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
4:35 PM
Aligos Therapeutics (Issuer)
Hirth Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:23 PM
Aligos Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G
02/08/2024
4:44 PM
Aligos Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SC 13D/A
01/30/2024
6:04 AM
Aligos Therapeutics (Subject)
Form SC TO-I
01/25/2024
5:06 AM
Aligos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
5:12 AM
Aligos Therapeutics (Subject)
Form SC TO-C
11/28/2023
3:01 PM
Aligos Therapeutics (Filer)
Form 424B3
11/27/2023
11:15 PM
Aligos Therapeutics (Filer)
Form EFFECT
11/17/2023
3:38 PM
Aligos Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/15/2023
3:01 PM
Aligos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
4:14 PM
Aligos Therapeutics (Issuer)
ROCHE FINANCE LTD (Reporting)
ROCHE HOLDING LTD (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2023
4:16 PM
Aligos Therapeutics (Subject)
ROCHE FINANCE LTD (Filed by)
Form SC 13G/A
11/07/2023
11:03 AM
Aligos Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/06/2023
3:05 PM
Aligos Therapeutics (Subject)
BLATT LAWRENCE (Filed by)
Form SC 13D
11/02/2023
3:23 PM
Aligos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/27/2023
3:13 PM
Aligos Therapeutics (Issuer)
Scopa James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2023
3:14 PM
Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2023
3:15 PM
Aligos Therapeutics (Issuer)
Nuechterlein Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2023
4:05 PM
Aligos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2023
7:45 AM
Aligos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2023
3:05 PM
Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
3:06 PM
Aligos Therapeutics (Issuer)
Symons Julian A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
3:07 PM
Aligos Therapeutics (Issuer)
Quan Lucinda Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
3:07 PM
Aligos Therapeutics (Issuer)
Calhoun Lesley Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
$1,500 to $9,400 in one month? (A.I. Trade List) (Ad)

This brand new A.I. Machine finds stocks and options trades which have had nearly PERFECT WIN RATES and gains as high as 1729%*

Click here to reserve your free seat
09/12/2023
3:08 PM
Aligos Therapeutics (Issuer)
McClure Matthew W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2023
3:01 PM
Aligos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2023
3:52 PM
Aligos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2023
8:06 PM
Aligos Therapeutics (Issuer)
Martell Bridget A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
6:23 PM
Aligos Therapeutics (Issuer)
Nielsen Jack (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
3:10 PM
Aligos Therapeutics (Issuer)
Nuechterlein Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
3:11 PM
Aligos Therapeutics (Issuer)
Scopa James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
3:13 PM
Aligos Therapeutics (Issuer)
Hirth Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ALGS) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners